The best peptides for body recomposition combine fat-loss compounds with growth hormone secretagogues that preserve lean tissue during caloric restriction. Unlike pure weight loss (scale weight) or pure bulking (muscle gain regardless of fat), body recomposition targets the simultaneous reduction of fat mass and maintenance — or growth — of lean mass. This is the most common actual goal among researchers studying metabolic peptides.

Every compound discussed in this guide is available from PSPeptides with third-party certificates of analysis. This article covers the metabolic side (fat loss), the anabolic side (muscle preservation), the recovery side (tissue support during recomp), and provides tiered stack recommendations with complete shopping lists.

What Makes Body Recomposition Different from Weight Loss?

Weight loss focuses on reducing total body mass — a scale number. Body recomposition focuses on changing the ratio of fat to lean tissue. A successful recomp protocol results in less fat and equal or greater muscle, even if scale weight changes minimally.

This distinction matters for peptide selection. Pure fat-loss compounds (like AOD-9604) address one half of the equation. Growth hormone secretagogues (like CJC-1295/Ipamorelin) address the other. A proper recomp stack pairs both categories, with optional recovery compounds to maintain tissue integrity during the metabolically demanding process.

The best peptides for weight loss guide covers fat-loss-only protocols. This guide is specifically about the dual goal of losing fat while preserving muscle — a more complex objective that requires a more sophisticated peptide selection.

The Metabolic Side: Peptides for Body Recomposition Fat Loss

Three compounds target fat metabolism through distinct mechanisms. Using multiple fat-loss pathways simultaneously creates broader metabolic coverage than any single compound.

Retatrutide: The Triple Agonist

Retatrutide is a triple-receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. This three-pathway approach makes it the most potent anti-obesity compound currently in clinical development.

The TRIUMPH-1 Phase 2 clinical trial data is remarkable: participants receiving the highest dose achieved 28.3% mean body weight reduction over 48 weeks. But what makes Retatrutide particularly relevant for body recomposition — rather than just weight loss — is the lean mass preservation data. The glucagon receptor agonism promotes hepatic fat oxidation and energy expenditure, while the GLP-1 and GIP pathways manage appetite and glucose homeostasis. The net effect is preferential fat loss with better lean mass retention compared to single-agonist GLP-1 drugs.

Published trial data is available through the New England Journal of Medicine (PubMed). The Retatrutide complete guide covers mechanism, dosing considerations, and trial outcomes. See also Retatrutide results for a breakdown of clinical endpoints.

Order now: Retatrutide from PSPeptides

AOD-9604: The Targeted Fat Fragment

AOD-9604 is a modified fragment of human growth hormone (amino acids 177-191). It replicates the fat-metabolism action of GH without the growth-promoting, insulin-resistant, or diabetogenic effects of full-length growth hormone.

AOD-9604 stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat creation) through a mechanism that does not involve the GH receptor. This means it targets fat cells directly without the muscle-building or organ-growth effects of GH — making it a pure fat-metabolism tool within a recomp stack.

Research demonstrated that AOD-9604 reduced body fat in obese animal models without affecting IGF-1 levels, food intake, or lean body mass. The absence of lean mass effects is precisely why it pairs well with GH secretagogues: AOD-9604 handles fat reduction while secretagogues handle lean mass preservation. Read the AOD-9604 research guide for complete mechanism and protocol analysis.

Order now: AOD-9604 from PSPeptides

MOTS-c: The Exercise Mimetic

MOTS-c is a mitochondrial-derived peptide that activates AMPK signaling, mimicking many metabolic benefits of exercise. In the context of body recomposition, MOTS-c improves glucose uptake, enhances fat oxidation, increases insulin sensitivity, and promotes metabolic efficiency.

Unlike Retatrutide (which addresses appetite and receptor-level metabolism) or AOD-9604 (which targets fat cells directly), MOTS-c works at the mitochondrial level — improving the cellular energy machinery that powers both fat burning and muscle function. Research in aged mice showed improved physical capacity and metabolic markers after MOTS-c treatment.

Within a recomp stack, MOTS-c functions as a metabolic enhancer that supports both sides of the equation: better fat utilization for energy and improved cellular efficiency for muscle maintenance. The MOTS-c mitochondrial peptide guide covers the full research base.

Order now: MOTS-c from PSPeptides

The Anabolic Side: Peptides for Lean Mass Preservation

Caloric restriction — even when targeting fat specifically — creates conditions where the body may catabolize lean tissue for energy. Growth hormone secretagogues counteract this by maintaining elevated GH and IGF-1 levels, which signal the body to preserve muscle protein rather than break it down for fuel.

CJC-1295/Ipamorelin Blend: The GH Secretagogue Standard

The CJC-1295/Ipamorelin blend is the most widely used GH secretagogue combination in peptide research. CJC-1295 is a GHRH analog that extends the duration of GH release, while Ipamorelin is a selective ghrelin receptor agonist that triggers clean GH pulses without cortisol or prolactin elevation.

For body recomposition, this blend serves a dual purpose. Elevated GH levels promote lipolysis (fat burning), contributing to the metabolic side. Simultaneously, elevated GH and the resulting IGF-1 increase support muscle protein synthesis and inhibit muscle protein breakdown — the anti-catabolic effect essential during caloric restriction.

Research demonstrated that CJC-1295 produced sustained GH elevation lasting 6-8 days after a single dose (PubMed). The CJC-1295/Ipamorelin growth hormone guide details the synergistic mechanism and protocol frameworks.

Order now: CJC-1295/Ipamorelin Blend from PSPeptides

MK-677 (Ibutamoren): The Oral GH Secretagogue

MK-677 is an oral GH secretagogue that activates the ghrelin receptor to increase growth hormone and IGF-1 levels. Its primary advantage in a recomp stack is convenience and sustained baseline elevation.

Because MK-677 is taken orally, it requires no reconstitution or injection. It provides a baseline GH/IGF-1 elevation that operates around the clock, complementing the acute pulses produced by injectable CJC-1295/Ipamorelin. During caloric restriction, this sustained GH elevation acts as a continuous anti-catabolic signal, protecting lean mass from breakdown.

Research showed that MK-677 reversed diet-induced nitrogen wasting — the loss of muscle protein that occurs during caloric deficit — demonstrating its anti-catabolic potential in precisely the conditions that body recomposition research creates (PubMed). The MK-677 Ibutamoren research guide covers dosing, timing, and long-term considerations.

Order now: MK-677 from PSPeptides

Sermorelin: The Natural GH Pulse Amplifier

Sermorelin is a GHRH analog consisting of the first 29 amino acids of the 44-amino-acid growth hormone releasing hormone. It amplifies the body’s natural GH pulse pattern rather than overriding it, making it one of the more physiological approaches to GH elevation.

In a recomp protocol, Sermorelin offers GH support with a more natural secretion pattern. Some researchers prefer it over CJC-1295/Ipamorelin for its shorter duration of action, which more closely mimics endogenous GH pulsatility. Others use it as an alternative for those who want GH support without the extended release window of CJC-1295.

Order now: Sermorelin from PSPeptides

The Recovery Side: Tissue Support During Recomposition

Body recomposition typically involves increased training intensity combined with caloric restriction — a metabolically stressful combination that increases injury risk and slows recovery. Two healing peptides provide targeted tissue support during this demanding phase.

BPC-157: Joint and Tendon Support

Increased training volume during recomp puts joints, tendons, and connective tissue under greater mechanical stress. BPC-157 accelerates tendon-to-bone healing, protects intestinal mucosa (relevant during dietary changes), and modulates the nitric oxide system for improved blood flow to stressed tissues.

For researchers running intensive protocols alongside metabolic and GH-elevating peptides, BPC-157 provides the connective tissue support that prevents training-related setbacks. The BPC-157 research guide and the peptides for joint and tendon repair guide cover the evidence in detail.

Order now: BPC-157 from PSPeptides

TB-500: Systemic Tissue Repair

Where BPC-157 acts locally, TB-500 provides systemic tissue repair support. It promotes cell migration and angiogenesis throughout the body, accelerating recovery from the accumulated micro-damage that intensive training creates during caloric restriction.

The combination of BPC-157 + TB-500 (the “Wolverine Stack”) is widely used as the recovery foundation for demanding protocols. PSPeptides also offers a pre-made BPC-157 + TB-500 blend for convenience.

Order now: TB-500 from PSPeptides | BPC-157 + TB-500 Blend

Recomp Stack Options: Basic, Intermediate, and Advanced

Not every researcher needs every compound. The table below organizes recomp stacks into three tiers based on complexity, budget, and research experience.

Basic tier is the minimum effective recomp stack: AOD-9604 for targeted fat metabolism plus MK-677 (oral, no injection) for GH-mediated lean mass protection. Two compounds, one injection, one oral capsule.

Intermediate tier upgrades fat loss to Retatrutide (the most potent metabolic compound available), adds the CJC-1295/Ipamorelin blend for targeted GH pulses, and includes the BPC-157 + TB-500 healing blend for recovery support.

Advanced tier layers all three fat-loss pathways (receptor-level, fat-cell-level, mitochondrial-level), both GH secretagogues (pulsatile + sustained), and both healing peptides (local + systemic). This is the most comprehensive recomp protocol available from a single vendor.

For guidance on combining these compounds, read the peptide stacking guide. New to peptides? The complete guide to peptides covers foundational concepts.

Protocol Timing: How to Schedule a Multi-Compound Recomp Stack

Running multiple peptides for body recomposition requires a structured administration schedule. Proper timing maximizes each compound’s efficacy while keeping the daily protocol manageable.

Morning administration. MOTS-c and AOD-9604 are commonly administered in the morning, aligning with the body’s daytime metabolic activity window. MOTS-c’s exercise-mimetic effects complement morning physical activity protocols. AOD-9604’s lipolytic action operates throughout the day when given in the morning.

Pre-sleep administration. CJC-1295/Ipamorelin is typically administered 30-60 minutes before sleep. Growth hormone is released in its largest natural pulses during slow-wave sleep, and CJC-1295/Ipamorelin amplifies these pulses. Aligning administration with this window maximizes GH output during the body’s peak repair and recovery period.

MK-677 timing. Because MK-677 increases appetite through ghrelin receptor activation, many researchers take it before bed to minimize appetite interference during waking hours while capturing its GH-elevating effects during sleep. The sustained IGF-1 elevation operates regardless of timing, but appetite management makes evening dosing practical for recomp protocols where caloric control matters.

Retatrutide timing. As a weekly injection compound (based on clinical trial protocols), Retatrutide does not require daily scheduling decisions. Most protocols use the same day each week for consistency.

Recovery compounds. BPC-157 and TB-500 are flexible in timing. Some researchers administer them post-training to align with tissue repair demand. Others prefer morning dosing for convenience. The BPC-157 dosage guide covers specific timing frameworks.

All injectable compounds require reconstitution with bacteriostatic water. Use the PSPeptides peptide calculator to determine the correct reconstitution volume and dosing for each compound in your stack.

Side Effects and Monitoring During Peptides for Body Recomposition Protocols

Multi-compound recomp stacks require attention to compound-specific side effects and their potential interactions. Review the peptide side effects guide before beginning any protocol.

GH secretagogue effects. Both CJC-1295/Ipamorelin and MK-677 elevate growth hormone, which can cause water retention, joint stiffness, and transient numbness in extremities. These effects are dose-dependent and typically resolve with dose adjustment. Monitor for changes in fasting blood glucose, as elevated GH can temporarily affect insulin sensitivity.

Retatrutide gastrointestinal effects. GLP-1 receptor agonists commonly cause nausea, particularly during the initial titration period. Clinical trials showed these effects diminished with gradual dose escalation. Starting at the lowest available dose and increasing incrementally over several weeks is standard protocol.

Appetite changes. Retatrutide suppresses appetite through GLP-1/GIP signaling. MK-677 increases appetite through ghrelin activation. In a combined protocol, these effects partially offset each other. Some researchers find this balance helpful — strong enough appetite suppression to maintain caloric restriction, without the complete anorexia that high-dose GLP-1 agonists alone can produce.

Complete Body Recomposition Shopping List

Every compound and supply needed for any tier of recomp stack, with direct links.

Use the PSPeptides peptide calculator for reconstitution volumes and dosing across all compounds. For reconstitution technique, see how to reconstitute peptides.

Why PSPeptides for Your Recomp Stack

A body recomposition protocol may involve 3-7 compounds plus supplies. Trust in your vendor matters at this scale.

Every compound in stock. Retatrutide, AOD-9604, MOTS-c, CJC-1295/Ipamorelin, MK-677, Sermorelin, BPC-157, TB-500 — all available in the PSPeptides shop. One order covers your entire stack.

Third-party COAs for every batch. With multiple compounds in a single protocol, verified purity is critical. Each vial ships with an independent certificate of analysis. View all certifications on the certifications page and learn to evaluate them with the COA reading guide.

Same-day shipping before 2 PM EST. Your complete recomp stack ships together and arrives as a single kit. No waiting on partial orders from multiple vendors.

Flexible payment. Multi-compound stacks represent a larger initial investment. Afterpay and Klarna split the order into interest-free installments. Credit and debit cards accepted. No cryptocurrency, no KYC, no SSN required.

Supplies bundled. BAC water, syringes, and injection pens ship alongside your peptides. Everything arrives together.

Frequently Asked Questions About Peptides for Body Recomposition

Can peptides really help achieve simultaneous fat loss and muscle preservation?

Yes, through complementary mechanisms. Fat-loss compounds like Retatrutide and AOD-9604 target fat metabolism directly. GH secretagogues like CJC-1295/Ipamorelin and MK-677 elevate growth hormone, which is both lipolytic (fat-burning) and anti-catabolic (muscle-sparing). Stacking both categories addresses both sides of the recomp equation.

What is the simplest body recomp stack for a beginner?

The Basic tier: AOD-9604 for fat metabolism plus MK-677 for oral GH elevation. Two compounds, minimal complexity, and MK-677 requires no injection or reconstitution. Add BAC water and syringes for the AOD-9604.

Do I need recovery peptides in a recomp stack?

If your research protocol involves increased physical stress (training intensity), recovery peptides like BPC-157 and TB-500 support joint, tendon, and connective tissue integrity under load. The pre-made blend simplifies addition. For lower-intensity protocols, the metabolic + lean mass compounds may be sufficient alone.

How does Retatrutide compare to GLP-1-only peptides for body recomposition?

Retatrutide is a triple agonist (GLP-1 + GIP + glucagon), while single-agonist compounds target only GLP-1. The glucagon component adds hepatic fat oxidation and energy expenditure, and the GIP component improves nutrient handling. Clinical data shows 28.3% mean weight reduction with Retatrutide versus lower numbers for single-agonist drugs. The Retatrutide guide compares trial outcomes in detail.

All PSPeptides products are sold exclusively for research and laboratory use.